A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe

Klaus Bønnelykke1, Patrick Sleiman2, Kasper Nielsen3

  • 11] Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen & Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark. [2] [3].

Nature Genetics
|November 19, 2013
PubMed

Insights

Severe childhood asthma exacerbations are linked to specific genetic factors. This study identified new and confirmed known asthma susceptibility genes, highlighting the importance of precise phenotyping in genetic research.

Area of Science:

  • Genetics
  • Pediatrics
  • Respiratory Medicine

Background:

  • Asthma exacerbations are a leading cause of childhood hospitalization.
  • The genetic underpinnings of severe, recurrent childhood asthma exacerbations remain largely unknown.
  • Previous genome-wide association studies (GWAS) have identified asthma susceptibility loci.

Purpose of the Study:

  • To identify novel genetic susceptibility loci for a specific asthma phenotype characterized by recurrent, severe exacerbations in early childhood.
  • To investigate the genetic architecture of severe pediatric asthma using a targeted phenotyping approach.

Main Methods:

  • A genome-wide association study (GWAS) was conducted on 1,173 cases with severe, recurrent asthma exacerbations (ages 2-6) and 2,522 controls.
  • Cases were identified using national health registries for hospitalizations.
  • DNA samples were sourced from the Danish Neonatal Screening Biobank.

Main Results:

  • Five loci demonstrated genome-wide significant association with the studied asthma phenotype.
  • Four previously identified asthma loci (GSDMB, IL33, RAD50, IL1RL1) showed larger effect sizes in this cohort compared to prior GWAS.
  • Strong evidence emerged for a novel susceptibility gene, CDHR3, highly expressed in airway epithelium.

Conclusions:

  • Specific phenotyping in genetic studies significantly enhances the discovery of asthma susceptibility genes.
  • The findings underscore the role of specific genetic factors, including CDHR3, in severe early-onset childhood asthma.
  • Larger effect sizes for known loci suggest a more specific genetic contribution in this defined asthma phenotype.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77